Time Posted:2023-08-23 17:19
Recently, Southern Weekly released the 2022 China Corporate Social Responsibility Survey list, and Joincare Pharmaceutical Group Industry Co., Ltd. and its subsidiary, Lizhu Pharmaceutical Group Co., Ltd., were both ranked among the top ten pharmaceutical companies in the social responsibility survey, ranking fourth and first respectively.
Time Posted:2023-08-22 17:24
On July 19, with the release of the "Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Development and Growth of the Private Economy", a number of specific support measures have further stimulated the vitality of the private economy's development. In order to better guide and support the high-quality development of the biomedicine and health industry in Pingshan District, recently, the Pingshan District Committee of the Shenzhen Municipal Committee of the CPC, in accordance with the pilot task requirements of the "2023 Work Points" undertaken by the District's Rule of Law Office, systematically strengthened the compliance construction of biomedicine enterprises in the district. Using the guidance of completing the compliance management system (ISO37301) certification and standardization as a lever, and aiming at high-quality legal services to support high-quality enterprise development, the district is comprehensively promoting the compliance construction of biomedicine enterprises.
Cool summer, another wave of blue storm
Time Posted:2023-08-21 17:00
Yi Ke Tie® Dexamethasone Acetate Oral Mucosal Adhesive Tablets
Time Posted:2023-08-18 14:47
Recently, Healthy Yuan (stock code: 600380.SH) disclosed the progress of its share repurchase plan. The announcement shows that from August 1, 2023 to August 9, 2023, the company repurchased 2,744,903 shares through centralized bidding, accounting for 0.14% of the company's total share capital, with a payment of RMB 32,043,100 (including handling fees). As of August 14, 2023, the company has repurchased a total of 45,957,211 shares, accounting for 2.40% of the company's total share capital, with a total payment of RMB 557,915,700 (including handling fees).
Time Posted:2023-08-16 19:19
Since the launch of the reform of the drug review and approval system, driven by multiple factors such as policy guidance, increased R&D investment, technological advancements, capital support, and the return of talent, China's innovative drug industry has experienced explosive growth. During this period, traditional pharmaceutical companies have undergone transformation, emerging Biotech companies have continued to grow, and domestic innovative drug R&D has yielded fruitful results.
Time Posted:2023-07-28 19:27
Recently, Health Yuan and Lizhu Group jointly launched a public welfare project to support rural revitalization in Balinzuoqi, Inner Mongolia, with a donation of medicines for chronic diseases. The launch ceremony was attended by Zhang Yan, Deputy Mayor of Balinzuoqi, and representatives from the Health and Health Commission, Red Cross Society, and Rural Revitalization Bureau of Balinzuoqi, as well as volunteers from Health Yuan and Lizhu Group.
Time Posted:2023-06-09 14:48
On June 7, Healthy Yuan and Lizhu Pharmaceutical Group joined hands to come to Huining County, Baiyin City, Gansu Province to fully support rural revitalization and promote chronic disease public welfare activities. A signing ceremony for the "Million Chronic Disease Drugs Public Welfare Donation" was held at the Third People's Hospital of Baiyin City.
Time Posted:2023-06-07 10:10
On May 10, 2023, the Guangdong Trademark Association announced the "2022 Guangdong Key Trademark Protection List," which includes the "Yiketie" trademark of Health Yuan Pharmaceutical Group. After review by the Guangdong Trademark Association's Key Trademark Protection Committee, "Yiketie" stood out among many trademark applications, demonstrating the industry and association's high recognition and support for Health Yuan's intellectual property protection work, as well as the brand's market recognition.